Advanced age no barrier to continuous myeloma regimen

VIENNA – Elderly patients over age 75 with newly diagnosed multiple myeloma derive the same survival benefits from continuous lenalidomide and low-dose dexamethasone as those under 75, according to a...

Field of Interest: Oncology
Type: News Item

Screen for hematologic cancers in SLE

SNOWMASS, COLO. – A full decade after a large multicenter study identified non-Hodgkin’s lymphoma as the major cancer risk associated with SLE, it... More »

Field of Interest: Rheumatology
Type: News Item

Oncology hospitalist field is small, but growing

Have you met an oncology hospitalist yet? If you haven’t, you probably will soon. The latest offshoot of hospital medicine aims to take all the strengths of the hospitalist movement – increased...

Field of Interest: Oncology
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness